Transition metal-catalysed higher-order carbocyclisation reactions represent an important class of reactions due to their ability to construct complex polycyclic systems in a highly selective and atom-economical fashion. A key and striking feature with these transformations is the dichotomy in reactivity that a substrate displays with different transition metal complexes, which is akin to the manner enzymes direct terpene biosynthesis. This tutorial review details the historical development of higher-order carbocyclisation reactions, specifically the variants of [m+2+2] that involve carbon-based pi-systems, where m = 2, 3 and 4, in the context of critical developments with various transition metal complexes.
Polycyclic structures that contain seven-membered carbocycles constitute important structural motifs that are ubiquitous in several classes of bioactive natural products. We have developed the first regio- and diastereoselective intermolecular rhodium-catalyzed [3+2+2] carbocyclization of carbon- and heteroatom-tethered alkenylidenecyclopropanes with mono- and disubstituted alkynes for the construction of cis-fused bicycloheptadienes. This study delineates some of the critical features for controlling regioselectivity in this process and demonstrates that E-alkenes can be incorporated in a stereospecific manner to afford products with up to three new stereogenic centers. The latter feature is particularly significant given that related carbocyclization reactions are often limited in this respect.
We developed a scalable Suzuki process for the synthesis of lanabecestat (+)-camsylate, an active pharmaceutical ingredient that was recently investigated in a Phase III clinical program for the treatment of early Alzheimer's disease. The evolution of this process culminated with the use of a stable and crystalline diethanolamine boronic ester that rapidly hydrolyses under the reaction conditions. Herein, we report that the liberated diethanolamine plays an important role in the catalytic process, with supporting evidence for an equilibrium between an unbound and bound palladium complex. Additionally, the diethanolamine acts as an internal scavenger during the crystallization of lanabecestat by increasing the solubility of the palladium species, obviating the need for a discrete scavenging step.
The isolation and characterization of a rhodacycle intermediate implicated in rhodium-catalyzed reactions of alkylidenecyclopropanes (ACPs) is described. The structure of the metallacycle was unambiguously determined by X-ray crystallography and is catalytically competent in the rhodium-catalyzed carbocyclization and ene-cycloisomerization reactions of ACPs. This work represents a rare example of the isolation of a metallacycle in a metal-catalyzed higher-order carbocyclization reaction and thereby provides important insight into the ligand requirements for the insertion of π-components. Furthermore, it serves as a convenient synthon for the development of challenging higher-order carbocyclization reactions, as exemplified by the reaction with an activated allene.
The rhodium-catalyzed ene-cycloisomerization of alkenylidenecyclopropanes provides an atom-economical approach to five-membered carbo- and heterocycles that contain two new stereogenic centers. A key and striking feature of this protocol is that the alkene geometry does not impact the efficiency and diastereocontrol, which provides excellent synthetic versatility. For instance, (E)- and (Z)-allylic alcohols furnish the corresponding aldehydes with similar efficiency and selectivity. This process facilitates the construction of a key intermediate in an eight-step total synthesis of (-)-α-kainic acid.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.